349 related articles for article (PubMed ID: 24445479)
1. Uricosuric drugs: the once and future therapy for hyperuricemia?
Bach MH; Simkin PA
Curr Opin Rheumatol; 2014 Mar; 26(2):169-75. PubMed ID: 24445479
[TBL] [Abstract][Full Text] [Related]
2. [Uricosuric agent].
Ohno I
Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.
Terkeltaub R; Bushinsky DA; Becker MA
Arthritis Res Ther; 2006; 8 Suppl 1(Suppl 1):S4. PubMed ID: 16820043
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.
Ao GZ; Zhou MZ; Li YY; Li SN; Wang HN; Wan QW; Li HQ; Hu QH
Bioorg Med Chem; 2017 Jan; 25(1):166-174. PubMed ID: 28340987
[TBL] [Abstract][Full Text] [Related]
5. Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout.
Tan PK; Liu S; Gunic E; Miner JN
Sci Rep; 2017 Apr; 7(1):665. PubMed ID: 28386072
[TBL] [Abstract][Full Text] [Related]
6. [Uric Acid Metabolism, Uric Acid Transporters and Dysuricemia].
Ichida K
Yakugaku Zasshi; 2024; 144(6):659-674. PubMed ID: 38825475
[TBL] [Abstract][Full Text] [Related]
7. Mulberroside a possesses potent uricosuric and nephroprotective effects in hyperuricemic mice.
Wang CP; Wang Y; Wang X; Zhang X; Ye JF; Hu LS; Kong LD
Planta Med; 2011 May; 77(8):786-94. PubMed ID: 21154198
[TBL] [Abstract][Full Text] [Related]
8. Urate transporters in the genomic era.
Sakurai H
Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):545-50. PubMed ID: 23852331
[TBL] [Abstract][Full Text] [Related]
9. Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout.
Hou Z; Ma A; Mao J; Song D; Zhao X
Expert Opin Drug Metab Toxicol; 2023 Dec; 19(12):895-909. PubMed ID: 37994776
[TBL] [Abstract][Full Text] [Related]
10. The molecular insight into the antihyperuricemic and renoprotective effect of Shuang Qi gout capsule in mice.
Kodithuwakku ND; Feng YD; Zhang YY; Pan M; Fang WR; Li YM
J Ethnopharmacol; 2015 Apr; 163():278-89. PubMed ID: 25614106
[TBL] [Abstract][Full Text] [Related]
11. New developments in clinically relevant mechanisms and treatment of hyperuricemia.
Lee SJ; Terkeltaub RA
Curr Rheumatol Rep; 2006 Jun; 8(3):224-30. PubMed ID: 16901081
[TBL] [Abstract][Full Text] [Related]
12. DKB114, A Mixture of
Lee YS; Kim SH; Yuk HJ; Kim DS
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274153
[No Abstract] [Full Text] [Related]
13. Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.
Jutabha P; Anzai N; Kitamura K; Taniguchi A; Kaneko S; Yan K; Yamada H; Shimada H; Kimura T; Katada T; Fukutomi T; Tomita K; Urano W; Yamanaka H; Seki G; Fujita T; Moriyama Y; Yamada A; Uchida S; Wempe MF; Endou H; Sakurai H
J Biol Chem; 2010 Nov; 285(45):35123-32. PubMed ID: 20810651
[TBL] [Abstract][Full Text] [Related]
14. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
[TBL] [Abstract][Full Text] [Related]
15. Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia.
Zhang Y; Jin L; Liu J; Wang W; Yu H; Li J; Chen Q; Wang T
J Ethnopharmacol; 2018 Mar; 214():29-36. PubMed ID: 29233733
[TBL] [Abstract][Full Text] [Related]
16. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
17. Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice.
Shi YW; Wang CP; Liu L; Liu YL; Wang X; Hong Y; Li Z; Kong LD
Mol Nutr Food Res; 2012 Sep; 56(9):1433-44. PubMed ID: 22865646
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor.
Taniguchi T; Ashizawa N; Matsumoto K; Saito R; Motoki K; Sakai M; Chikamatsu N; Hagihara C; Hashiba M; Iwanaga T
J Pharmacol Exp Ther; 2019 Oct; 371(1):162-170. PubMed ID: 31371478
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.
Anzai N; Jutabha P; Amonpatumrat-Takahashi S; Sakurai H
Clin Exp Nephrol; 2012 Feb; 16(1):89-95. PubMed ID: 22038265
[TBL] [Abstract][Full Text] [Related]
20. Betaine reduces serum uric acid levels and improves kidney function in hyperuricemic mice.
Liu YL; Pan Y; Wang X; Fan CY; Zhu Q; Li JM; Wang SJ; Kong LD
Planta Med; 2014 Jan; 80(1):39-47. PubMed ID: 24338552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
